BioMarin Pharmaceutical Ownership | Who Owns BioMarin Pharmaceutical?


OverviewForecastRevenueFinancialsChartTranscripts

BioMarin Pharmaceutical Ownership Summary


BioMarin Pharmaceutical is owned by 95.98% institutional investors, 0.95% insiders, and 3.07% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 12.35% of BMRN shares. Dodge & Cox Stock I is the top mutual fund, with 5.13% of its assets in BioMarin Pharmaceutical shares.

BMRN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBioMarin Pharmaceutical95.98%0.95%3.07%
SectorHealthcare Stocks 57.43%9.41%33.16%
IndustryBiotech Stocks 69.02%8.92%22.06%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de23.51M12.35%$1.55B
Blackrock22.74M12.04%$1.87B
Vanguard group19.37M10.17%$1.27B
Primecap management co/ca/18.19M9.55%$1.20B
Dodge & cox14.75M7.74%$969.27M
Capital research global investors12.99M6.82%$853.94M
Viking global investors lp10.51M5.52%$690.86M
State street9.11M4.79%$598.94M
Ameriprise financial4.50M2.36%$295.80M
Norges bank3.57M1.87%$234.64M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Palo alto investors lp1.07M10.87%$70.15M
Eagle health investments lp419.21K6.75%$27.55M
Sector gamma as217.35K4.91%$14.29M
Soleus capital management1.00M4.14%$65.82M
Vestal point capital, lp860.00K3.35%$56.53M
Clearline capital lp377.48K3.28%$24.81M
Viking global investors lp10.51M2.24%$690.86M
Novo490.00K1.95%$32.21M
Rhenman & partners asset management ab250.62K1.69%$16.47M
Elliott investment management3.50M1.38%$230.08M

Top Buyers

HolderShares% AssetsChange
Blackrock22.74M0.04%8.26M
Norges bank3.57M0.03%3.57M
Capital research global investors12.99M0.18%2.50M
Soleus capital management1.00M4.14%1.00M
Blackrock funding, inc. /de23.51M0.03%889.61K

Top Sellers

HolderShares% AssetsChange
Jpmorgan chase1.55M0.01%-1.27M
1832 asset management---1.16M
Parnassus investments---873.00K
Neuberger berman group93.75K0.00%-803.83K
Primecap management co/ca/18.19M0.93%-678.26K

New Positions

HolderShares% AssetsChangeValue
Norges bank3.57M0.03%3.57M$234.64M
Soleus capital management1.00M4.14%1.00M$65.82M
Susquehanna fundamental investments169.48K0.16%169.48K$11.14M
Nomura126.84K0.01%126.84K$8.34M
Raymond james financial81.81K0.00%81.81K$5.38M

Sold Out

HolderChange
Bryn mawr trust-2.00
Householder group estate & retirement specialist-3.00
Abich financial wealth management-5.00
Financial gravity asset management-7.00
Sanctuary wealth management-9.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024565-5.04%182,776,8923.30%951.11%2852.15%178-10.55%
Sep 30, 2024591-0.17%176,679,197-4.12%920.97%279-3.13%1957.14%
Jun 30, 2024583-2.35%184,215,3300.81%971.04%28513.55%178-13.17%
Mar 31, 20245973.29%182,743,407-1.16%961.00%251-4.56%2053.02%
Dec 31, 20235787.04%184,894,3974.31%981.11%26314.85%1996.99%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Dodge & Cox Stock I9.77M5.13%855.60K
Capital Group Growth Fnd of Amer Comp7.54M3.96%2.57M
American Funds Growth Fund of Amer A7.54M3.96%2.57M
Vanguard PRIMECAP Inv7.17M3.76%-105.72K
iShares Core S&P Mid-Cap ETF6.18M3.24%-1.01K
Vanguard Total Stock Mkt Idx Inv6.01M3.15%12.12K
Vanguard Capital Opportunity Inv5.51M2.89%-39.91K
Capital Group AMCAP Composite4.49M2.36%-115.70K
American Funds AMCAP A4.49M2.36%-115.70K
VA CollegeAmerica Amcap 529A4.49M2.36%-115.70K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 06, 2025Guyer Charles Greg EVP, Chief Technical OfficerSell$501.36K
Feb 24, 2025Burkhart Erin GVP, Chief Accounting OfficerSell$91.90K
Nov 12, 2024Guyer Charles Greg EVP, Chief Technical OfficerSell$350.32K
Aug 13, 2024Burkhart Erin GVP, Chief Accounting OfficerSell$64.26K
May 30, 2024Mueller Brian EVP, Chief Financial OfficerSell$375.95K

Insider Transactions Trends


DateBuySell
2025 Q1-2
2024 Q4-1
2024 Q3-1
2024 Q2-10
2024 Q1-10

BMRN Ownership FAQ


Who Owns BioMarin Pharmaceutical?

BioMarin Pharmaceutical shareholders are primarily institutional investors at 95.98%, followed by 0.95% insiders and 3.07% retail investors. The average institutional ownership in BioMarin Pharmaceutical's industry, Biotech Stocks , is 69.02%, which BioMarin Pharmaceutical exceeds.

Who owns the most shares of BioMarin Pharmaceutical?

BioMarin Pharmaceutical’s largest shareholders are Blackrock funding, inc. /de (23.51M shares, 12.35%), Blackrock (22.74M shares, 12.04%), and Vanguard group (19.37M shares, 10.17%). Together, they hold 34.56% of BioMarin Pharmaceutical’s total shares outstanding.

Does Blackrock own BioMarin Pharmaceutical?

Yes, BlackRock owns 12.04% of BioMarin Pharmaceutical, totaling 22.74M shares as of Jun 2024. This represents 0.04% of BlackRock's total assets, with a market value of 1.87B$. In the last quarter, BlackRock increased its holdings by 8.26M shares, a 57.05% change.

Who is BioMarin Pharmaceutical’s biggest shareholder by percentage of total assets invested?

Palo alto investors lp is BioMarin Pharmaceutical’s biggest shareholder by percentage of total assets invested, with 10.87% of its assets in 1.07M BioMarin Pharmaceutical shares, valued at 70.15M$.

Who is the top mutual fund holder of BioMarin Pharmaceutical shares?

Dodge & Cox Stock I is the top mutual fund holder of BioMarin Pharmaceutical shares, with 5.13% of its total shares outstanding invested in 9.77M BioMarin Pharmaceutical shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools